Perinatal Neonatal Quality Improvement Network Spring Summit, 6/26/24

Norwood, MA US
June 26, 2024

Claiming Credit for Session
Thank you for attending PNQIN Spring Summit meeting on June 26, 2024. Once logged in, please click on "Take Course" on the right-hand side and your enrollment will be recorded. You will be prompted to take an evaluation to claim your credit on the following page.

Educational Needs Addressed
In this meeting, PNQIN reviewed their latest projects, their role in driving change in maternal and neonatal inequities and how they can better integrate families into quality improvement work. The goal is to improve attendees understanding of patient, family and community engagement in advancing equity in maternal and neonatal care.

Target Audience

PNQIN providers including physicians, nurses, nurse practitioners, physician assistants and social workers.

Learning Objectives

At the completion of this activity participants will be better able to:

  • Integrate disparate economic, policy and clinical areas into a strategy for intervention.
  • Recognize common circumstances and factors that contribute to pregnancy-related deaths.
  • Examine the impact of mental concerns in perinatal individuals through a biological, psychological and social/political and trauma responsive context.
  • Assess how Integrating Families into QI work and Advisories improves collaboration and care.
  • Describe the new CMS regulations on social needs screening and their implications for maternal and child health providers.
  • Summarize the findings and recommendations from the Integrating Narratives of SUD treatment in the Perinatal period: A focus on Race and Ethnicity (INSPiRE) Project.
  • Describe the current projects being implemented by PNQIN and their partners related to obstetrics, neonatology, and/or the care of people experiencing perinatal opioid use disorders.
Course summary
Available credit: 
  • 6.50 AMA PRA Category 1 Credit™

    Boston University Chobanian & Avedisian School of Medicine designates this Live activity for a maximum of 6.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    • 2.75 MA Opioid Education Statement
  • 6.50 ANCC
  • 6.50 Social Work (ACE)
  • 6.50 Participation
Course opens: 
06/26/2024
Course expires: 
07/26/2024
Event starts: 
06/26/2024 - 8:30am EDT
Event ends: 
06/26/2024 - 4:30pm EDT
Rating: 
5
Four Points by Sheraton
1125 Boston Providence Turnpike
Norwood, MA 02062
United States

Faculty Presenters and Disclosures
Ron Iverson, MD, MPH
Course Director
Obstetrician/Gynecologist BMC
Co-Chair
Perinatal Neonatal Quality Improvement Network of Massachusetts

The following speakers have no relevant financial relationships to disclose:Allison Bryant, Ginny Combs, Stephanie Crawford, Molly Fraust-Wylie, Latisha Goullaud, Emily Herzberg, Ron Iverson, Linda Jablonski, Ruth Jacobson-Hardy, Rohan Khazanchi, Divya Kumar, Elysia Larson, Jen Lee, Kristie Leeman, Elaine Fitzgerald Lewis, Kiame Mahaniah; Melissa Maitland, Kassie Merrill, Caroline Miklovich, Leena Mittal, Tierney Morrison, Mimi Pomerleau, Gaby Cordova Ramos, Leela Sarathy, Davida Schiff, Michele Schultz, Kim Shapiro, Josefa Sherer, Amanda Small, Cheryl Slater, Kara Stires, Elise Vanetzian, Julyvette Vasquez, Kate Walsh, Kali Vitek.

Dr. Audra Meadows, planner and speaker, is a consultant for Ferring Pharmaceuticals.
Dr. Tiffany Moore-Simas receives grant research supporrt from Perigee and is a speaker for Miller Medical Communications.

Off-Label Discussion
The faculty members do not plan on discussing the unlabeled/investigational use of any commercial products. 

Planning Committee and Disclosures
Beth Buxton, LCSW, Social Worker Accreditation Reviewer; Ronald Iverson, MD, MPH, Course Director; Kristie Leeman, MD; Audra Meadows, MD, MPH; Meg Parker, MD; Mimi Pomerlau, DNP, CNE Accreditation Reviewer;  Christin Price, MD; Aviel Peaceman, MPH; Cheryl Slater, MSN-ED, Nurse Advisor; Caroline Somerville, Kali Vitek, MPH and Amy Walker , CNM of PNQIN have no relevant financial relationships to disclose.

Dr. Audra Meadows, planner and speaker, is a consultant for Ferring Pharmaceuticals.

Accreditor Disclosures
The following planning committee members from Boston University Chobanian & Avedisian School of Medicine’s Office of Continuing Medical Education have no relevant financial relationships to disclose: Michael Burk, BS – Operations Manager.

Accreditor Disclosure Policy
Boston University Chobanian & Avedisian School of Medicine asks all individuals involved in the development and presentation of Accredited Continuing Education activities to disclose all financial relationships with ineligible companies. This information is disclosed to all activity participants prior to the start of the educational activity. Boston University Chobanian & Avedisian School of Medicine has procedures to mitigate all relevant financial relationships with ineligible companies. In addition, faculty members are asked to disclose when any unapproved use of pharmaceuticals and devices is being discussed.

In accordance with the Standards for Integrity and Independence in Accredited Continuing Education, all relevant financial relationships with ineligible companies that faculty, planners, authors and anyone who may be in control of content have been mitigated.

Disclaimer
THESE MATERIALS AND ALL OTHER MATERIALS PROVIDED IN CONJUNCTION WITH CONTINUING EDUCATION ACTIVITIES ARE INTENDED SOLELY FOR PURPOSES OF SUPPLEMENTING CONTINUING EDUCATION PROGRAMS FOR QUALIFIED HEALTH CARE PROFESSIONALS.  ANYONE USING THE MATERIALS ASSUMES FULL RESPONSIBILITY AND ALL RISK FOR THEIR APPROPRIATE USE.  TRUSTEES OF BOSTON UNIVERSITY MAKES NO WARRANTIES OR REPRESENTATIONS WHATSOEVER REGARDING THE ACCURACY, COMPLETENESS, CURRENTNESS, NONINFRINGEMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE OF THE MATERIALS.  IN NO EVENT WILL TRUSTEES OF BOSTON UNIVERSITY BE LIABLE TO ANYONE FOR ANY DECISION MADE OR ACTION TAKEN IN RELIANCE ON THE MATERIALS.  IN NO EVENT SHOULD THE INFORMATION IN THE MATERIALS BE USED AS A SUBSTITUTE FOR PROFESSIONAL CARE.  IN NO EVENT SHOULD INFORMATION IN THE MATERIALS REGARDING LAWS, REGULATIONS, OR LEGAL LIABILITY BE CONSIDERED LEGAL ADVICE OR USED AS A SUBSTITUTE FOR CONSULTING WITH AN ATTORNEY.

 

Joint Accreditation
In support of improving patient care, this activity has been planned and implemented by Boston University Chobanian & Avedisian School of Medicine and Perinatal Neonatal Quality Improvement Network (PNQIN). Boston University Chobanian & Avedisian School of Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

 



 

CME Accreditation 
Boston University Chobanian & Avedisian School of Medicine designates this live activity for a maximum of 6.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ANCC Accreditation
Contact Hours: 6.5

Social Work Accreditation 
As a Jointly Accredited Organization, Boston University Chobanian & Avedisian School of Medicine is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. Regulatory boards are the final authority on courses accepted for continuing education credit. Social workers completing this course receive 6.5 continuing education credits.

Opioid Education/Pain Management Training
This program meets the criteria of the Massachusetts Board of Registration in Medicine for 2.75 hours of opioid education

 

Available Credit

  • 6.50 AMA PRA Category 1 Credit™

    Boston University Chobanian & Avedisian School of Medicine designates this Live activity for a maximum of 6.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    • 2.75 MA Opioid Education Statement
  • 6.50 ANCC
  • 6.50 Social Work (ACE)
  • 6.50 Participation
Please login or register to take this course.